Company

AbbVie’s China General Manager Ou Silang Steps Down, Intercon’s Colzi to Take Interim Role

CompanyDrug

Allist Pharmaceuticals’ Furmonertinib Receives NMPA Approval for Two Clinical Trials

CompanyDrug

Everest Medicines’ Nefecon NDA Accepted for Review by Singapore’s HSA

CompanyDrug

Hutchison China Meditech Initiates Two Phase II Studies for HMPL-453 and Orpathys

CompanyDeals

Evopoint Biosciences Partners with Merck for Phase Ib/II Study Combining XNW5004 and Keytruda

CompanyDeals

AstraZeneca and HKSTP Expand Collaboration with MoU to Support Start-Ups

CompanyDrug

CStone Pharmaceuticals’ Sugemalimab Files for New Indication with NMPA for Esophageal Cancer

CompanyDrug

Biosion Receives FDA Approval for Phase II Study of TSLP mAb BSI-045B

CompanyDeals

Shanghai Best-Link Bioscience Secures $29 Million in Series A Financing for Nano Drug Innovation

CompanyDrug

OncoSec Medical’s TAVO-EP Combo Misses Primary Endpoint in Melanoma Trial

Company

Legend Biotech Corporation Appoints Industry Veterans to Strategic Advisory Board

Policy / Regulatory

Beijing-Tianjin-Hebei Alliance Completes VBP Tender for Coronary Intervention Devices with 78.29% Price Cut